Elon Musk's company Neuralink received the green light from the US Food and Drug Administration (FDA) to test brain implants on humans.
"FDA approval is an important first step that will somehow allow our technology to help many people," Neuralink said.
The company said it is not yet recruiting participants and plans to reveal more details of the research in the near future.
According to Elon Musk, neurochips can cure a number of diseases, including obesity, autism, depression, schizophrenia and others. Moreover, last year the billionaire was so confident in the safety of the technology that he declared his readiness to implant it in his children.
Neuralink only applied for FDA approval in early 2022, but the agency rejected the company's application. The administration pointed to a number of issues that needed to be resolved before granting approval for human trials. The problems, in turn, related to:
of the lithium battery of the device; possibilities of migration of implant wires in the brain; safe removal of the device without damage to the brain tissue.
There were also cases when the company got into scandals. For example, last year an investigation began against Neuralink due to information about the death of at least 1,500 animals during implant tests.